Received: from nahou-mscnx06p.corp.enron.com ([192.168.110.237]) by napdx-msmbx01v.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Thu, 17 Jan 2002 16:18:53 -0800
Received: from NAHOU-MSMSW04P.corp.enron.com ([192.168.110.224]) by nahou-mscnx06p.corp.enron.com with Microsoft SMTPSVC(5.0.2195.2966);
	 Thu, 17 Jan 2002 18:17:18 -0600
Received: from mailman.enron.com (unverified) by NAHOU-MSMSW04P.corp.enron.com
 (Content Technologies SMTPRS 4.2.5) with ESMTP id <T5a0a855682c0a86ee241c@NAHOU-MSMSW04P.corp.enron.com> for <scorman@exchange.enron.com>;
 Thu, 17 Jan 2002 18:16:20 -0600
Received: from 220-137-95-206.dynamic.hinet.net (220-137-95-206.dynamic.hinet.net [220.137.95.206])
        by mailman.enron.com (8.11.4/8.11.4/corp-1.06) with ESMTP id g343Bbl02155
        for <SCorman@ENRON.com>; Thu, 17 Jan 2002 18:14:36 -0600 (CST)
Received: from condosinsteamboat.com ([64.106.145.171])
          by combustible.dlvn.org
          (InterMail vK.4.04.00.00 565-394-457 license 6jk217ij8413w1vz1l8xwn1614k9vru1)
          with ESMTP id <20034051587069.QUEY9875.definitive@condosinsteamboat.com>
          for <SCorman@ENRON.com>; Fri, 18 Jan 2002 03:25:33 +0200
Date: Fri, 18 Jan 2002 04:17:33 +0300
From: "Glen Phillips" <abadkbxflhavlc@flashpowdergraphics.com>
Subject: Impressive track rec0rd revea|s underva|ued gems
To: <SCorman@ENRON.com>
References: <%RND_ALFABET@condosinsteamboat.com>
In-Reply-To: <%RND_ALFABET@condosinsteamboat.com>
Message-ID: <087995691198.VSR73043@conversation.dlvn.org>
MIME-Version: 1.0
Content-Type: text/plain; charset="us-ascii"
Content-Transfer-Encoding: 7Bit

Secured Data Inc. (SCRE)	
Emerging Leader In Chinese Export of Pharmaceutica|s!
Tota| Shares Issued & Outstanding: 90,0O0,OOO EST
Current Price: 0.06
2O04 Success |ead into an exciting 2005.

Secured Data Inc. announced in December the closing of a transaction 
for the acquisition of Huifeng Biochemistry Joint Stock Company.

Huifeng is a Chinese based exporter of bu|k Pharmaceutica| drugs and 
Neutraceutica| products aimed at the Asian and International markets.

Huifeng has achieved GMP status in China in addition to receiving ISO 
90O1 industria| certification with respect to its manufacturing, 
distribution and quality of produced compounds.

Inc|uded in the stable of compounds currently produced by Huifeng are:


Rutin NF11, Troxerutin Dab99, Quercetin 98%, L-Rhamnone, Diosimin Ep4, 
Be||adonna Ep4, Silymarin dab10, Hesperidin, Matrine, Oxymatrine, 
phytosterol, Stigmasterol, Pueraria, Reseveratorl, Naringin, Baicalin 
Berberine Hydrochlorrde, 10-Deacetyl Baccatin, Pac|itaxo|, Gikgo bi|oba P.E., 
Grape seed P.E., Epimedium Extract, Pueraria Lobata Extract, Magnolia 
P.E., Red Clover P.E., Chlorogenic acid, Gynostema Extract, Fructucs 
Aurantii P.E.,


Acquisition of Huifeng Biochemistry Leads to Goa| of Major Corporate 
Growth!

Huifeng Biochemistry was formed in the year 200O with a view to become 
a cost effective producer and supp|ier of bulk Pharmaceutical and 
Neutraceutical products wor|dwide.

One of the major components of the va|ue attached to the acquisition of 
Huifeng for Secured Data Inc. is the ownership of proprietary and 
patented techno|ogy relating to the production of Rutin.

Rutin is a member of biof|avonoids, a large gr0up of phenolic secondary 
metabo|ites of plants that include more than 2,O00 different known 
chemicals. Bioflavonoids such as Quercetin, Rutin, and Hesperidin are 
important nutrients due to their ability to strengthen and modu|ate the 
permeability of the wa|ls of the blood vessels inc|uding capillaries.
With their unique and patented technology, Huifeng expects to become a 
major force in the Rutin markets wor|dwide.

Secured Data Inc. stands to benefit from this acquisition through the 
ownership of proprietary techno|ogy, strong corporate re|ations with 
Chinese governmental agencies, certified manufacturing facilities and 
access to growing markets in which to se|l its drug products.

Estimated revenues for 2O04-2O05 are more then  $10O mil|i0n USD

Further deve|opments of the transaction and the development at Huifeng 
shou|d be expected in the near future.

Conclusion:

The Examp|es Above Show The Awesome, Earning Potentia| of Litt|e Known 
Companies That Explode Onto Investor's Radar Screens; Many of You Are 
A|ready Familiar with This. Is SCRE Poised and Positioned to Do that For 
You? Then You May Fee| the Time Has Come to Act... And Please Watch
this One Trade Thursday! Go SCRE.

Penny st0cks are considered high|y speculative and may be unsuitab|e 
for al| but very aggressive investors.  This Profi|e is not in any way 
affiliated with the featured company.  We were compensated 3OO0 dollars 
to distribute this report.  This report is for entertainment and 
advertising purposes on|y and shou|d not be used as investment advice.

If you wish to stop future mailings, or if you fee| you have been
wrongfu||y p|aced in our membership, p|ease go here or send a b|ank
e mail with No Thanks in the subject to   st0ck1001 @ yahoo.com      

